Long-acting β₂ Adrenergic Receptor Agonists (LABA)

Long-acting β₂ Adrenergic Receptor Agonists (LABA) are compounds that selectively stimulate β₂ adrenergic receptors in the lungs, causing bronchodilation and helping to relax smooth muscle in the airways. LABA are commonly used in the treatment of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD) due to their prolonged action. At CymitQuimica, we provide a wide selection of LABA compounds for research into respiratory pharmacology and therapeutic applications.

20
- 50
- 100
- 200

products per page. 331 products on this category.

Product data	Purity	Price range	Estimated delivery
Salmeterol Resolution Check REF: 45-1609589	- - -	1,475.00 €	Tue 27 May 25
Salmeterol Related Compound B (4-{1-Hydroxy-2-[6-(4-phenylbutan-2-yloxy)hexylamino]ethyl}-2- REF: 45-1609625CAS: 108928-81-0	- - -	1,477.00 €	Tue 27 May 25
Salmeterol Xinafoate REF: 45-1609603CAS: 94749-08-3	- - -	1,210.00 €	Tue 27 May 25
Phenylpropoxy Salmeterol (4-(1-hydroxy-2-((6-(3-phenylpropoxy)hexyl)amino)ethyl)-2-(hydroxymethyl)phenol; 4-{1-Hydroxy-2-[6-(3-phenylpropoxy)hexylamino]ethyl}-2-(hydroxymethyl)phenol) REF: 45-1A04700CAS: 94749-11-8	- - -	2,406.00 €	Tue 27 May 25
Phenylethoxy Salmeterol (4-(1-hydroxy-2-((6-phenethoxyhexyl)amino)ethyl)-2-(hydroxymethyl)phenol) REF: 45-1A04690CAS: 94749-02-7	- - -	1,227.00 €	Tue 27 May 25
Fluticasone Propionate Related Compound J (6α, 9α-difluoro-11β,17α-dihydroxy-16α-methyl-3-oxoandrosta-1,4-diene-17β-carboxylic acid) REF: 45-1285818CAS: 28416-82-2	- - -	1,477.00 €	Tue 27 May 25
Deoxy Salmeterol (4-(1-hydroxy-2-((6-(4-phenylbutoxy)hexyl)amino)ethyl)-2-methylphenol) REF: 45-1A04710CAS: 1391054-40-2	- - -	1,554.00 €	Tue 27 May 25
Fluticasone Propionate Related Compound D (6α,9-Difluoro-11β-hydroxy-16α-methyl-17-[(methylsulfanyl)carbonyl]-3-oxoandrosta-1,4-dien-17α-yl propanoate) REF: 45-1285829CAS: 73205-13-7	- - -	1,477.00 €	Tue 27 May 25
Fluticasone Propionate REF: 45-1285873CAS: 80474-14-2	- - -	2,063.00 €	Tue 27 May 25
Salmeterol Related Compound A (4-[1-Hydroxy-2-(4-phenylbutylamino)ethyl]-2-(hydroxymethyl)phenol 1-hydroxy-2-naphthoate) REF: 45-1609614CAS: 1798014-51-3	- - -	1,699.00 €	Tue 27 May 25
Salmeterol System Suitability (Mixture containing salmeterol xinafoate, salmeterol-N-alkyl and salmeterol related compound H) REF: 45-1609590	- - -	1,555.00 €	Tue 27 May 25
4-Phenylbutyl(benzyl)amine hydrochloride (N-benzyl-4-phenylbutan-1-amine, hydrochloride) REF: 45-1A04820CAS: 144391-74-2	- - -	1,227.00 €	Tue 27 May 25
Salmeterol Related Compound H (1-Hydroxy-4-[2-hydroxy-5-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)benzyl]-2-naphthoic acid, monohydrate) REF: 45-1609680CAS: 3079028-47-7	- - -	1,627.00 €	Tue 27 May 25
Indacaterol maleate REF: TM-T1239CAS: 753498-25-8	99.03% - 99.67%	35.00 €~145.00 €	Tue 27 May 25
Salmeterol REF: TM-T12829CAS: 89365-50-4	99.87% - 99.9%	55.00 €~458.00 €	Tue 27 May 25
Olodaterol REF: TM-T3457CAS: 868049-49-4	98.9%	49.00 €~579.00 €	Tue 27 May 25
Bromo Formoterol REF: 4Z-F-1149	- - -	1,107.00 €~9,048.00 €	Wed 28 May 25
Formoterol Impurity 29 REF: 4Z-F-1155	- - -	1,107.00 €~9,048.00 €	Wed 28 May 25
Formoterol Sulfate Ammonium Salt REF: 4Z-F-118CAS: 250336-08-4	- - -	1,554.00 €~12,686.00 €	Wed 28 May 25
Formoterol Impurity 30 HCl REF: 4Z-F-1126CAS: 1049695-95-5	- - -	300.00 €~1,237.00 €	Wed 28 May 25

10mg		35.00 €
25mg		52.00 €
50mg		74.00 €
100mg		97.00 €
200mg		145.00 €
1mL*10mM (DMSO)		55.00 €

5mg		55.00 €
10mg		88.00 €
25mg		154.00 €
50mg		274.00 €
1mL*10mM (DMSO)		77.00 €

5mg		1,107.00 €
10mg		1,823.00 €
25mg		3,385.00 €
50mg		5,468.00 €
100mg		9,048.00 €

5mg		1,554.00 €
10mg		2,589.00 €
25mg		4,660.00 €
50mg		7,702.00 €
100mg		12,686.00 €

5mg		300.00 €
10mg		477.00 €
25mg		681.00 €
50mg		885.00 €
100mg		1,237.00 €

Long-acting β₂ Adrenergic Receptor Agonists (LABA)

Salmeterol Resolution Check

Ref: 45-1609589

Salmeterol Related Compound B (4-{1-Hydroxy-2-[6-(4-phenylbutan-2-yloxy)hexylamino]ethyl}-2-

Ref: 45-1609625

Salmeterol Xinafoate

Ref: 45-1609603

Phenylpropoxy Salmeterol (4-(1-hydroxy-2-((6-(3-phenylpropoxy)hexyl)amino)ethyl)-2-(hydroxymethyl)phenol; 4-{1-Hydroxy-2-[6-(3-phenylpropoxy)hexylamino]ethyl}-2-(hydroxymethyl)phenol)

Ref: 45-1A04700

Phenylethoxy Salmeterol (4-(1-hydroxy-2-((6-phenethoxyhexyl)amino)ethyl)-2-(hydroxymethyl)phenol)

Ref: 45-1A04690

Fluticasone Propionate Related Compound J (6α, 9α-difluoro-11β,17α-dihydroxy-16α-methyl-3-oxoandrosta-1,4-diene-17β-carboxylic acid)

Ref: 45-1285818

Deoxy Salmeterol (4-(1-hydroxy-2-((6-(4-phenylbutoxy)hexyl)amino)ethyl)-2-methylphenol)

Ref: 45-1A04710

Fluticasone Propionate Related Compound D (6α,9-Difluoro-11β-hydroxy-16α-methyl-17-[(methylsulfanyl)carbonyl]-3-oxoandrosta-1,4-dien-17α-yl propanoate)

Ref: 45-1285829

Fluticasone Propionate

Ref: 45-1285873

Salmeterol Related Compound A (4-[1-Hydroxy-2-(4-phenylbutylamino)ethyl]-2-(hydroxymethyl)phenol 1-hydroxy-2-naphthoate)

Ref: 45-1609614

Salmeterol System Suitability (Mixture containing salmeterol xinafoate, salmeterol-N-alkyl and salmeterol related compound H)

Ref: 45-1609590

4-Phenylbutyl(benzyl)amine hydrochloride (N-benzyl-4-phenylbutan-1-amine, hydrochloride)

Ref: 45-1A04820

Salmeterol Related Compound H (1-Hydroxy-4-[2-hydroxy-5-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)benzyl]-2-naphthoic acid, monohydrate)

Ref: 45-1609680

Indacaterol maleate

Ref: TM-T1239

Salmeterol

Ref: TM-T12829

Olodaterol

Ref: TM-T3457

Bromo Formoterol

Ref: 4Z-F-1149

Formoterol Impurity 29

Ref: 4Z-F-1155

Formoterol Sulfate Ammonium Salt

Ref: 4Z-F-118

Formoterol Impurity 30 HCl

Ref: 4Z-F-1126